Health status of young children with cancer following discontinuation of therapy

G. Pastore, M. G. Zurlo, A. Acquaviva, G. Calculli, M. Castello, A. Ceci, M. L. Di Tullio, S. Gandus, P. Macchia, L. Cordero Di Montezemolo, F. Mandelli, F. Massolo, L. Nespoli, G. Paolucci, M. Rosate, E. Senesi, P. Tamaro, U. Tripoli, B. Terracini

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma [NBL], 57 Wilms' tumor [WT], 46 acute lymphoblastic leukemia [ALL], and 3 non‐Hodgkin's lymphomal was followed for 1‐12 years after discontinuation of therapy. Thirty‐three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurrences of the primary cancer, and three from other causes; eight were alive with evidence of primary cancer; and eight were lost to follow‐up. Kyphoscoliosis was found in 22 children and other musculoskeletal anomalies in 8. Neurological sequelae were observed in 8 out 35 children with ALL treated with radiotherapy (RT) and intrathecal methotrexate. All but one were in continous complete remission when they developed seizures (three cases), leukoencephalopathy (three cases), or intracerebral calcitications (two cases). One child had cardiomyopathy and subsequently died from cardiac failure: he had received doxorubicin (400 mg/m2) and mediastinal RT (13 Gy) for NBL. Growth impairments were observed in children with NBL and WT.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalMedical and Pediatric Oncology
Volume15
Issue number1
DOIs
Publication statusPublished - 1987

Fingerprint

Health Status
Neoplasms
Neuroblastoma
Wilms Tumor
Therapeutics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Radiotherapy
Leukoencephalopathies
Cardiomyopathies
Methotrexate
Doxorubicin
Leukemia
Seizures
Heart Failure
Pediatrics
Physicians
Recurrence
Growth

Keywords

  • acute lymphoblastic leukemia
  • childhood cancer
  • late effects

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Pastore, G., Zurlo, M. G., Acquaviva, A., Calculli, G., Castello, M., Ceci, A., ... Terracini, B. (1987). Health status of young children with cancer following discontinuation of therapy. Medical and Pediatric Oncology, 15(1), 1-6. https://doi.org/10.1002/mpo.2950150102

Health status of young children with cancer following discontinuation of therapy. / Pastore, G.; Zurlo, M. G.; Acquaviva, A.; Calculli, G.; Castello, M.; Ceci, A.; Di Tullio, M. L.; Gandus, S.; Macchia, P.; Di Montezemolo, L. Cordero; Mandelli, F.; Massolo, F.; Nespoli, L.; Paolucci, G.; Rosate, M.; Senesi, E.; Tamaro, P.; Tripoli, U.; Terracini, B.

In: Medical and Pediatric Oncology, Vol. 15, No. 1, 1987, p. 1-6.

Research output: Contribution to journalArticle

Pastore, G, Zurlo, MG, Acquaviva, A, Calculli, G, Castello, M, Ceci, A, Di Tullio, ML, Gandus, S, Macchia, P, Di Montezemolo, LC, Mandelli, F, Massolo, F, Nespoli, L, Paolucci, G, Rosate, M, Senesi, E, Tamaro, P, Tripoli, U & Terracini, B 1987, 'Health status of young children with cancer following discontinuation of therapy', Medical and Pediatric Oncology, vol. 15, no. 1, pp. 1-6. https://doi.org/10.1002/mpo.2950150102
Pastore, G. ; Zurlo, M. G. ; Acquaviva, A. ; Calculli, G. ; Castello, M. ; Ceci, A. ; Di Tullio, M. L. ; Gandus, S. ; Macchia, P. ; Di Montezemolo, L. Cordero ; Mandelli, F. ; Massolo, F. ; Nespoli, L. ; Paolucci, G. ; Rosate, M. ; Senesi, E. ; Tamaro, P. ; Tripoli, U. ; Terracini, B. / Health status of young children with cancer following discontinuation of therapy. In: Medical and Pediatric Oncology. 1987 ; Vol. 15, No. 1. pp. 1-6.
@article{9012e865f893465fb3efa3c3dfd6b250,
title = "Health status of young children with cancer following discontinuation of therapy",
abstract = "This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma [NBL], 57 Wilms' tumor [WT], 46 acute lymphoblastic leukemia [ALL], and 3 non‐Hodgkin's lymphomal was followed for 1‐12 years after discontinuation of therapy. Thirty‐three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurrences of the primary cancer, and three from other causes; eight were alive with evidence of primary cancer; and eight were lost to follow‐up. Kyphoscoliosis was found in 22 children and other musculoskeletal anomalies in 8. Neurological sequelae were observed in 8 out 35 children with ALL treated with radiotherapy (RT) and intrathecal methotrexate. All but one were in continous complete remission when they developed seizures (three cases), leukoencephalopathy (three cases), or intracerebral calcitications (two cases). One child had cardiomyopathy and subsequently died from cardiac failure: he had received doxorubicin (400 mg/m2) and mediastinal RT (13 Gy) for NBL. Growth impairments were observed in children with NBL and WT.",
keywords = "acute lymphoblastic leukemia, childhood cancer, late effects",
author = "G. Pastore and Zurlo, {M. G.} and A. Acquaviva and G. Calculli and M. Castello and A. Ceci and {Di Tullio}, {M. L.} and S. Gandus and P. Macchia and {Di Montezemolo}, {L. Cordero} and F. Mandelli and F. Massolo and L. Nespoli and G. Paolucci and M. Rosate and E. Senesi and P. Tamaro and U. Tripoli and B. Terracini",
year = "1987",
doi = "10.1002/mpo.2950150102",
language = "English",
volume = "15",
pages = "1--6",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Health status of young children with cancer following discontinuation of therapy

AU - Pastore, G.

AU - Zurlo, M. G.

AU - Acquaviva, A.

AU - Calculli, G.

AU - Castello, M.

AU - Ceci, A.

AU - Di Tullio, M. L.

AU - Gandus, S.

AU - Macchia, P.

AU - Di Montezemolo, L. Cordero

AU - Mandelli, F.

AU - Massolo, F.

AU - Nespoli, L.

AU - Paolucci, G.

AU - Rosate, M.

AU - Senesi, E.

AU - Tamaro, P.

AU - Tripoli, U.

AU - Terracini, B.

PY - 1987

Y1 - 1987

N2 - This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma [NBL], 57 Wilms' tumor [WT], 46 acute lymphoblastic leukemia [ALL], and 3 non‐Hodgkin's lymphomal was followed for 1‐12 years after discontinuation of therapy. Thirty‐three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurrences of the primary cancer, and three from other causes; eight were alive with evidence of primary cancer; and eight were lost to follow‐up. Kyphoscoliosis was found in 22 children and other musculoskeletal anomalies in 8. Neurological sequelae were observed in 8 out 35 children with ALL treated with radiotherapy (RT) and intrathecal methotrexate. All but one were in continous complete remission when they developed seizures (three cases), leukoencephalopathy (three cases), or intracerebral calcitications (two cases). One child had cardiomyopathy and subsequently died from cardiac failure: he had received doxorubicin (400 mg/m2) and mediastinal RT (13 Gy) for NBL. Growth impairments were observed in children with NBL and WT.

AB - This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma [NBL], 57 Wilms' tumor [WT], 46 acute lymphoblastic leukemia [ALL], and 3 non‐Hodgkin's lymphomal was followed for 1‐12 years after discontinuation of therapy. Thirty‐three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurrences of the primary cancer, and three from other causes; eight were alive with evidence of primary cancer; and eight were lost to follow‐up. Kyphoscoliosis was found in 22 children and other musculoskeletal anomalies in 8. Neurological sequelae were observed in 8 out 35 children with ALL treated with radiotherapy (RT) and intrathecal methotrexate. All but one were in continous complete remission when they developed seizures (three cases), leukoencephalopathy (three cases), or intracerebral calcitications (two cases). One child had cardiomyopathy and subsequently died from cardiac failure: he had received doxorubicin (400 mg/m2) and mediastinal RT (13 Gy) for NBL. Growth impairments were observed in children with NBL and WT.

KW - acute lymphoblastic leukemia

KW - childhood cancer

KW - late effects

UR - http://www.scopus.com/inward/record.url?scp=0023248422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023248422&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950150102

DO - 10.1002/mpo.2950150102

M3 - Article

VL - 15

SP - 1

EP - 6

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 1

ER -